{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:13Z","timestamp":1791297913593,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T00:00:00Z","timestamp":1396483200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090458","type":"journal-article","created":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T16:36:30Z","timestamp":1396542990000},"page":"e90458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["High-Throughput Screening for the Identification of New Therapeutic Options for Metastatic Pheochromocytoma and Paraganglioma"],"prefix":"10.1371","volume":"9","author":[{"given":"Alessio","family":"Giubellino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Shankavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Bullova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schovanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Elkahloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Trepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jhh.2012.20","article-title":"An update on the genetics of pheochromocytoma","volume":"27","author":"D Karasek","year":"2013","journal-title":"J Hum Hypertens"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0032-1304594","article-title":"A decade (2001\u20132010) of genetic testing for pheochromocytoma and paraganglioma","volume":"44","author":"A Buffet","year":"2012","journal-title":"Horm Metab Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0031-1301302","article-title":"An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes","volume":"44","author":"AP Gimenez-Roqueplo","year":"2012","journal-title":"Horm Metab Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"A Cascon","year":"2012","journal-title":"Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.seminoncol.2010.10.017","article-title":"Metastatic paraganglioma","volume":"37","author":"SM Fliedner","year":"2010","journal-title":"Semin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1055\/s-0029-1231025","article-title":"Treatment of malignant pheochromocytoma","volume":"41","author":"R Adjalle","year":"2009","journal-title":"Horm Metab Res"},{"key":"ref8","article-title":"Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma","author":"C Jimenez","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1634\/theoncologist.2008-0043","article-title":"Pheochromocytoma: current approaches and future directions","volume":"13","author":"JT Adler","year":"2008","journal-title":"Oncologist"},{"key":"ref10","first-page":"141","article-title":"Pheochromocytoma: implications in tumorigenesis and the actual management","volume":"37","author":"U Shah","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1158\/0008-5472.CAN-11-3439","article-title":"Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnership","volume":"72","author":"SJ Weir","year":"2012","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1476-4598-7-82","article-title":"The prince and the pauper. A tale of anticancer targeted agents","volume":"7","author":"A Duenas-Gonzalez","year":"2008","journal-title":"Mol Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrd3461","article-title":"Mining for therapeutic gold","volume":"10","author":"FS Collins","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","article-title":"Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations","volume":"29","author":"KS King","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jc.2010-1946","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","author":"M Ayala-Ramirez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"80ps16","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"R Huang","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"I Comino-Mendez","year":"2011","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1093\/hmg\/dds374","article-title":"Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma","volume":"21","author":"N Burnichon","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10585-009-9236-0","article-title":"Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature","volume":"26","author":"L Martiniova","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"J Inglese","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00441-010-0965-9","article-title":"Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla","volume":"340","author":"SM Fliedner","year":"2010","journal-title":"Cell Tissue Res"},{"key":"ref22","unstructured":"Team RDC (2010) R: A Language and Environment for Statistical Computing."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1158\/0008-5472.CAN-05-4610","article-title":"Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis","volume":"66","author":"CS Schuetz","year":"2006","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1593\/neo.122132","article-title":"Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas","volume":"15","author":"U Shankavaram","year":"2013","journal-title":"Neoplasia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/gb-2010-11-5-r53","article-title":"A human functional protein interaction network and its application to cancer data analysis","volume":"11","author":"G Wu","year":"2010","journal-title":"Genome Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"TC Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e56083","DOI":"10.1371\/journal.pone.0056083","article-title":"Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma","volume":"8","author":"A Giubellino","year":"2013","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdg358","article-title":"Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline","volume":"14","author":"M Nakane","year":"2003","journal-title":"Ann Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/cbt.19848","article-title":"Combination of HDAC and topoisomerase inhibitors in small cell lung cancer","volume":"13","author":"J Gray","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MED.0b013e32835fcc45","article-title":"Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options","volume":"20","author":"A Vicha","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref33","first-page":"883","article-title":"Animal models of pheochromocytoma","volume":"19","author":"AS Tischler","year":"2004","journal-title":"Histol Histopathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/MCB.15.7.3470","article-title":"The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max","volume":"15","author":"R Hopewell","year":"1995","journal-title":"Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s004410000290","article-title":"Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice","volume":"302","author":"JF Powers","year":"2000","journal-title":"Cell Tissue Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"JA DiMasi","year":"2003","journal-title":"J Health Econ"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/bib\/bbr021","article-title":"Drug repositioning for orphan diseases","volume":"12","author":"D Sardana","year":"2011","journal-title":"Brief Bioinform"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1096\/fj.12-210146","article-title":"Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function","volume":"26","author":"C Yang","year":"2012","journal-title":"FASEB J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1677\/ERC-10-0090","article-title":"Increased uptake of [(1)(2)(3)I]meta-iodobenzylguanidine, [(1)F]fluorodopamine, and [(3)H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors","volume":"18","author":"L Martiniova","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"ref40","article-title":"NF-kappaB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model","author":"K Pacak","year":"2012","journal-title":"Int J Cancer"},{"key":"ref41","article-title":"Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor","author":"JK Killian","year":"2013","journal-title":"Cancer Discov"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T22:07:02Z","timestamp":1540332422000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090458"}},"subtitle":[],"editor":[{"given":"Manfred","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}